Newron Pharmaceuticals S.p.A. (NWPHF)
OTCMKTS · Delayed Price · Currency is USD
12.00
+0.60 (5.26%)
May 15, 2024, 9:30 AM EDT
Newron Pharmaceuticals Employees
Newron Pharmaceuticals had 22 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
22
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$2,418,376
Profits / Employee
$745,560
Market Cap
232.98M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 22 | 0 | - |
Dec 31, 2023 | 22 | -1 | -4.35% |
Dec 31, 2022 | 23 | -2 | -8.00% |
Dec 31, 2021 | 25 | 2 | 8.70% |
Dec 31, 2020 | 23 | -3 | -11.54% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Elite Pharmaceuticals | 68 |
Tian'an Technology Group | 8 |
Glass House Brands | 374 |
CytoDyn | 13 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Jushi Holdings | 1,234 |
Newron Pharmaceuticals News
- 4 weeks ago - Newron Begins Enrollment in Pivotal Phase III ENIGMA-TRS Program With Evenamide as Add-on Therapy in Patients With Treatment-Resistant Schizophrenia (TRS) - Business Wire
- 4 weeks ago - Newron Notes the Publication of New Preclinical Research Suggesting Evenamide Ameliorates Schizophrenia-Related Dysfunction - Business Wire
- 2 months ago - Edison Issues Report on Newron Pharmaceuticals (NWRN) - Newsfile Corp
- 4 months ago - Newron Announces Approval for Pivotal Phase III ENIGMA-TRS Program With Evenamide as Add-on Therapy in Patients With Treatment-resistant Schizophrenia (TRS) - Business Wire
- 5 months ago - Newron Presents 2024 Financial Results and Provides 2025 Outlook - Business Wire
- 6 months ago - Newron Pharmaceuticals to Participate in a Fireside Chat at the 37th Annual ROTH Conference - Business Wire
- 8 months ago - Newron and Myung In Pharm Announce License Agreement for evenamide in South Korea - Business Wire
- 9 months ago - Newron and EA Pharma (A Subsidiary of Eisai Co., Ltd.) Announce License Agreement for Evenamide in Japan and Other Asian Territories - Business Wire